Remdesivir is an antiviral drug mainly used to treat infections caused by certain RNA viruses. It is also used to treat mild to moderate COVID-19 in non-hospitalized patients who are at high risk for progression to severe COVID-19. It is grouped under the following drug class(es): Nucleotides. Its therapeutic use is listed as anti-infectives and antivirals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Veklury, remdesivirum and GS-5734. Its PubChem CID is 121304016.
Remdesivir
| CAS No | 1809249-37-3 |
|---|---|
| Molecular Formula | C27H35N6O8P |
| Molecular Weight | 602.6 g/mol |
| Synonyms | 2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Remdesivir is an antiviral drug mainly used to treat infections caused by certain RNA viruses. It is also used to treat mild to moderate COVID-19 in non-hospitalized patients who are at high risk for progression to severe COVID-19.
The listed CAS number is 1809249-37-3.
The listed molecular formula is C27H35N6O8P.
The listed molecular weight is 602.6 g/mol.
2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate.
The source lists Veklury, remdesivirum and GS-5734.